Citations 62

The Third Universal Definition of Myocardial Infarction—Moving Forward

Clinical Chemistry | November 28, 2012 | Volume: 58 | Issue: 12 | Pages: 1727-1728

10.1373/clinchem.2012.196832 | PMID 23326853

Longitudinal Studies of Cardiac Troponin I in a Large Cohort of Healthy Children

Clinical Chemistry | September 28, 2012 | Volume: 58 | Issue: 12 | Pages: 1665-1672

10.1373/clinchem.2012.192054 | PMID 23019308

BACKGROUND There is little information available on cardiac troponin concentrations in healthy young children. METHODS Using a precommercial high-sensitivity assay from Abbott Diagnostics, we measured cardiac troponin I (cTnI) in longitudinal blood samples collected at ages 8, 10, and 12 years from a cohort of healthy, community-dwelling children. The 99th percentile values were calculated and estimates of the long-term biological variation were made. RESULTS cTnI concentrations were above the limit of detection in 87%, 90%, and 98% of the children at ages 8, 10, and 12 years. The 99th percentiles were lower compared to a healthy adult population in both male and female children at all ages studied. At the 3 periods of study assessment, different children had cTnI concentrations above the 99th percentile. The calculated 99th percentile varied markedly depending upon whether the lowest or highest cTnI measurement for an individual child was included in the calculation. Biological variation varied markedly between 0% and 136%, the index of individuality was low at 0.36, and the reference change value was an increase of 147% or a decrease of 59%. CONCLUSIONS In this longitudinal study of cTnI concentrations in healthy children as determined by a high-sensitivity assay, different children had concentrations of cTnI above the 99th percentile at the 3 episodes of assessment. These results suggest that in children the 99th percentile may not be a reliable index of silent cardiac disease, but rather may be indicating low-grade intercurrent illness.
Clinical Implications of a Recent Adjustment to the High-Sensitivity Cardiac Troponin T Assay: User Beware

Clinical Chemistry | September 12, 2012 | Volume: 58 | Issue: 11 | Pages: 1599-1600

10.1373/clinchem.2012.194985 | PMID 22968106

It’s Time for a Change to a Troponin Standard

Circulation | June 12, 2012 | Volume: 102 | Issue: 11 | Pages: 1216-1220

10.1161/01.cir.102.11.1216 | PMID 10982533

In Reply

Clinical Chemistry | May 20, 2010 | Volume: 56 | Issue: 7 | Pages: 1199-1200

10.1373/clinchem.2010.148460

Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myoc

Clinical Chemistry | April 1, 2010 | Volume: 56 | Issue: 6 | Pages: 941-943

10.1373/clinchem.2010.143958 | PMID 20360122

High-Sensitivity Cardiac Troponin: Hype, Help, and Reality

Clinical Chemistry | December 30, 2009 | Volume: 56 | Issue: 3 | Pages: 342-344

10.1373/clinchem.2009.136218 | PMID 20040616

Refining Our Criteria

American Journal of Clinical Pathology | December 19, 2008 | Volume: 131 | Issue: 1 | Pages: 11-13

10.1309/ajcpfydy7b2aydze | PMID 19095560

Cross-Reactivity of BNP, NT-proBNP, and proBNP in Commercial BNP and NT-proBNP Assays: Preliminary Observations from the IFCC Committee for Standardization of Markers of Cardiac Damage

Clinical Chemistry | February 29, 2008 | Volume: 54 | Issue: 3 | Pages: 619-621

10.1373/clinchem.2007.097998 | PMID 18310156

Letter Regarding Article by Khan et al, “Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis”

Circulation | May 22, 2006 | Volume: 113 | Issue: 20 | Pages: No page available

10.1161/circulationaha.105.607341 | PMID 16717158